Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus

Pharma Market Access Insights - from Mtech Access

With new policy passing power to Integrated Care Systems (ICS), we explore how pharmacy and medicines commissioning will work in the new system, with Laura Angus (Interim Lead Pharmacist, Humber, Coast and Vale ICS)
In our December #WhispersWordsofWisdom webinar, Tom Clarke was joined by Laura Angus who, in her new appointment as a Lead Pharmacist in an Integrated Care System (ICS), is currently evaluating the impact of the transfers of budget and decision-making power from Clinical Commissioning Groups (CCGs) to an ICS. Her appointment as Interim Lead Pharmacist at Humber Coast and Vale ICS in November, follows 7-years as Head of Prescribing at NHS Vale of York CCG.
Laura shares her frontline insights into the structural changes in the NHS, and what this means for pharmacy and the role of medicines.
This episode was originally broadcast on 15th December 2020 as a webinar.
Learn more about our NHS insights services at: https://mtechaccess.co.uk/uk-nhs-insights/

Subscribe to our newsletter to hear more news, insights and events from Mtech Access.

บท

1. Pharmacy and Medicines in the Integrated Care Systems (ICS) of the new NHS with Laura Angus (00:00:00)

2. What does your role involve and what are pharmacy leaders focusing on? (00:03:30)

3. What is the footprint of your ICS and who is involved? (00:10:15)

4. What will you do at an ICS level? What will be the ICS's priorities and how will money flow? (00:15:30)

5. How do you collaborate with and learn from other ICS? (00:22:00)

6. How do you evaluate success? (00:28:05)

7. Is there an opportunity to change how medicines (and pharmacy) are perceived? (00:32:15)

8. A dispersed leadership model for pharmacy in the ICS (00:38:20)

9. What are your priorities for the future of the pharmacy workforce? (00:42:15)

10. Digital as an enabler for pharmacy (00:45:17)

11. Integrating pharmacy with other areas of health and social care (00:48:35)

12. Move of specialised commissioning from national level to ICS level (00:51:10)

13. What role could the pharmaceutical industry play in supporting the future medicines landscape? (00:55:53)